Page last updated: 2024-08-21

pyrazines and trametinib

pyrazines has been researched along with trametinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Downward, J; Hancock, DC; Herbert, E; Horswell, S; Janes, MR; Li, LS; Molina-Arcas, M; Moore, C; Mugarza, E; Rana, S; Romero-Clavijo, P; van Maldegem, F	1

Other Studies

1 other study(ies) available for pyrazines and trametinib

Article	Year
Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer. Science translational medicine, 2019, 09-18, Volume: 11, Issue:510 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Survival; Imidazoles; Lung Neoplasms; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Mutation; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins p21(ras); Pyrazines; Pyridones; Pyrimidinones; Receptor, IGF Type 1; RNA, Small Interfering; Signal Transduction; TOR Serine-Threonine Kinases	2019

Article

Year

Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer.

Science translational medicine, 2019, 09-18, Volume: 11, Issue:510

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Survival; Imidazoles; Lung Neoplasms; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Mutation; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins p21(ras); Pyrazines; Pyridones; Pyrimidinones; Receptor, IGF Type 1; RNA, Small Interfering; Signal Transduction; TOR Serine-Threonine Kinases

2019